Evidence map›Paper›PMID 28005008›Full record

ArticleeLife2016

Angiopoietin receptor Tie2 is required for vein specification and maintenance via regulating COUP-TFII.

Man Chu, Taotao Li, Bin Shen, Xudong Cao, Haoyu Zhong, Luqing Zhang, Fei Zhou, Wenjuan Ma, Haijuan Jiang, Pancheng Xie and 12 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it, 75 citations in OpenAlex.

  1. Pooled it
  2. Cell-Specific Roles of Angiopoietin-2 in CKD.Journal of the American Society of Nephrology : JASN · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Receptor tyrosine kinase inhibitors in cancer.Cellular and molecular life sciences : CMLS · 2023
    Review
  18. Angiopoietin-1 Is Required for Vortex Vein and Choriocapillaris Development in Mice.Arteriosclerosis, thrombosis, and vascular biology · 2022
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 5 institutions in 4 countries.

Man Chu *Cyrus Tang Hematology Center, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.
Taotao Li *Cyrus Tang Hematology Center, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.
Bin ShenCyrus Tang Hematology Center, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.
Xudong CaoCyrus Tang Hematology Center, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.
Haoyu ZhongCyrus Tang Hematology Center, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.
Luqing ZhangCyrus Tang Hematology Center, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.
Fei ZhouCyrus Tang Hematology Center, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.ORCID http://orcid.org/0000-0003-1857-8831
Wenjuan MaCyrus Tang Hematology Center, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.
Haijuan JiangCyrus Tang Hematology Center, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.
Pancheng XieCam-Su Genomic Resources Center, Soochow University, Suzhou, China.
Zhengzheng LiuCyrus Tang Hematology Center, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.
Ningzheng DongCyrus Tang Hematology Center, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.
Ying XuCam-Su Genomic Resources Center, Soochow University, Suzhou, China.ORCID http://orcid.org/0000-0002-6689-7768
Yun ZhaoCyrus Tang Hematology Center, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.
Guoqiang XuCollege of Pharmaceutical Sciences, Soochow University, Suzhou, China.
Peirong LuThe First Affiliated Hospital, Soochow University, Suzhou, China.
Jincai LuoLaboratory of Vascular Biology, Institute of Molecular Medicine, Peking University, Beijing, China.
Qingyu WuCyrus Tang Hematology Center, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.
Kari AlitaloWihuri Research Institute and Translational Cancer Biology Center of Excellence, Biomedicum Helsinki University of Helsinki, Helsinki, Finland.
Gou Young KohCenter for Vascular Research, Institute of Basic Science and Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Korea.
Ralf H AdamsMax-Planck-Institute for Molecular Biomedicine, Department of Tissue Morphogenesis, Faculty of Medicine, University of Münster, Münster, Germany.
Yulong HeCyrus Tang Hematology Center, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.ORCID http://orcid.org/0000-0002-0099-3749
Soochow University · CNKorea Advanced Institute of Science and Technology · KRPeking University · CNUniversity of Helsinki · FIUniversity of Münster · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mechanisms underlying the vein development remain largely unknown. Tie2 signaling mediates endothelial cell (EC) survival and vascular maturation and its activating mutations are linked to venous malformations. Here we show that vein formation are disrupted in mouse skin and mesentery when Tie2 signals are diminished by targeted deletion of

Indexed as

AnimalsCOUP Transcription Factor IIEndothelial CellsGene DeletionGene TargetingMesenteryMiceProto-Oncogene Proteins c-aktReceptor, TIE-2RetinaSkinVeinsCOUP Transcription Factor IINr2f2 protein, mouseProto-Oncogene Proteins c-aktReceptor, TIE-2Tek protein, mouseCOUP-TFIIdevelopmental biologymousestem cellsTie2vein specification

Identifiers

PMID28005008
PMCPMC5218530
OpenAlexW2564572464

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.